Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
137,278,139
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
78,095,522
-
Shares change
-
+3,590,719
-
Total reported value, excl. options
-
$3,252,220,942
-
Value change
-
+$158,691,641
-
Put/Call ratio
-
1.2%
-
Number of buys
-
125
-
Number of sells
-
-74
-
Price
-
$41.87
Significant Holders of Vir Biotechnology, Inc. - Common Stock (VIR) as of Q4 2021
247 filings reported holding VIR - Vir Biotechnology, Inc. - Common Stock as of Q4 2021.
Vir Biotechnology, Inc. - Common Stock (VIR) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78,095,522 shares
of 137,278,139 outstanding shares and own 56.89% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (22,216,644 shares), VANGUARD GROUP INC (7,330,131 shares), Temasek Holdings (Private) Ltd (5,537,291 shares), Capital International Investors (5,505,566 shares), BlackRock Inc. (5,308,049 shares), BAILLIE GIFFORD & CO (3,915,501 shares), ALLIANCEBERNSTEIN L.P. (2,620,753 shares), STATE STREET CORP (2,528,107 shares), Alaska Permanent Fund Corp (2,300,000 shares), and Point72 Asset Management, L.P. (2,055,100 shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.